Five months after acquiring the cell therapy company ImmPACT Bio, Lyell Immunopharma has disclosed that it is shutting down the Los Angeles manufacturing facility that was part of the deal and letting go of 73 people at the site. The layoffs are effective June 2, according to a Worker Adjustment and Retraining Notification Act (WARN) notice.
